CDKN2A and goblet cell carcinoma: Kanthan and colleagues [16] published an interesting study evaluating goblet cell adenocarcinoma (GCA) and reported that their high cellular proliferation rate was a consequence of cell cycle dysregulation, in particular, with upregulation of cyclin D1 and p21, and downregulation of p16.